Can a phenotype for recessive inheritance in breast cancer be defined?

Familial Cancer

Volumn 9, Issue 4, 2010, Pages 525-530

  Ellberg, Carolina ^a   Jönsson, Göran ^a   Olsson, Håkan ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Familial breast cancer; Horizontal inheritance; Recessive inheritance; Tubular breast cancer; Vertical inheritance

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; HORMONE RECEPTOR; PROTEIN P53;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SCREENING; CANCER SURVIVAL; DISTANT METASTASIS; FAMILY HISTORY; GENE MUTATION; GERM LINE; HETEROZYGOTE; HORMONE SUBSTITUTION; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; RECESSIVE INHERITANCE; TUMOR CLASSIFICATION; TUMOR SUPPRESSOR GENE; TUMOR VOLUME;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; CARCINOMA, MEDULLARY; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; GENES, RECESSIVE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HORMONE REPLACEMENT THERAPY; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; MUTATION; PHENOTYPE; POLYMERASE CHAIN REACTION; PREGNANCY; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 78650212150     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-010-9355-4     Document Type: Article

References (19)

1. JM O'Brien 2000 Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland, by P. Lichtenstein, N.V. Holm, P.K. Verkasalo, A. Iliadou, J. Kaprio, M. Koskenvuo, E. Pukkala, A. Skytthe, and K. Hemminki. N Engl J Med 343:78-84
2. 2000 Surv Ophthalmol 45 2 167 168 10.1016/S0039-6257(00)00165-X 11033045
3. J Peto TM Mack 2000 High constant incidence in twins and other relatives of women with breast cancer Nat Genet 26 4 411 414 1:CAS:528: DC%2BD3cXptVWgsbY%3D 10.1038/82533 11101836
4. DF Easton 1999 How many more breast cancer predisposition genes are there? Breast Cancer Res 1 1 14 17 1:CAS:528:DC%2BD3cXlsFKgs7s%3D 10.1186/bcr6 11250676 (Pubitemid 32223529)
5. T Ripperger D Gadzicki A Meindl B Schlegelberger 2009 Breast cancer susceptibility: current knowledge and implications for genetic counselling Eur J Hum Genet 17 6 722 731 1:CAS:528:DC%2BD1MXmtFKnsLg%3D 10.1038/ejhg.2008.212 19092773
6. MR Stratton N Rahman 2008 The emerging landscape of breast cancer susceptibility Nat Genet 40 1 17 22 1:CAS:528:DC%2BD1cXhtVyrsQ%3D%3D 10.1038/ng.2007.53 18163131
7. P Athma R Rappaport M Swift 1996 Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer Cancer Genet Cytogenet 92 2 130 134 1:STN:280:DyaK2s7jtVKjtA%3D%3D 10.1016/S0165- 4608(96)00328-7 8976369 (Pubitemid 26427675)
8. AM Goldstein CI Amos 1990 Segregation analysis of breast cancer from the cancer and steroid hormone study: histologic subtypes J Natl Cancer Inst 82 24 1911 1917 1:STN:280:DyaK3M%2Fms1emuw%3D%3D 10.1093/jnci/82.24.1911 2174465
9. CI Amos AM Goldstein EL Harris 1991 Familiality of breast cancer and socioeconomic status in blacks Cancer Res 51 7 1793 1797 1:STN:280: DyaK3M7mvVWmsw%3D%3D 2004364
10. DJ Ciske SS Rich RA King, et al. 1996 Segregation analysis of breast cancer: a comparison of type-dependent age-at-onset versus type-dependent susceptibility models Genet Epidemiol 13 4 317 328 1:STN:280: DyaK2s%2FkvF2jtQ%3D%3D 10.1002/(SICI)1098-2272(1996)13:4<317::AID-GEPI1>3. 0.CO;2-1 8894635 (Pubitemid 26330935)
11. AC Antoniou PD Pharoah G McMullan NE Day BA Ponder D Easton 2001 Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study Genet Epidemiol 21 1 1 18 1:STN:280: DC%2BD3MzovVGltQ%3D%3D 10.1002/gepi.1014 11443730 (Pubitemid 32619211)
12. DJ Kaufman TH Beaty JP Struewing 2003 Segregation analysis of 231 Ashkenazi Jewish families for evidence of additional breast cancer susceptibility genes Cancer Epidemiol Biomarkers Prev 12 10 1045 1052 1:CAS:528:DC%2BD3sXosVCru7o%3D 14578141 (Pubitemid 37310261)
13. E Anderson J Berg R Black, et al. 2008 Predicting breast cancer risk: implications of a "weak" family history Fam Cancer 7 4 361 366 10.1007/s10689-008-9197-5 18560993
14. Olsson HL (2009) Lobular breast carcinoma as a possible candidate phenotype for recessively inherited breast cancer. Cancer Res 69(2):119S-S
15. CI Li JR Daling KE Malone, et al. 2006 Relationship between established breast cancer risk factors and risk of seven different histologic types of invasive breast cancer Cancer Epidemiol Biomarkers Prev 15 5 946 954 10.1158/1055-9965.EPI-05-0881 16702375 (Pubitemid 43823522)
16. MD Lagios MR Rose FR Margolin 1980 Tubular carcinoma of the breast: association with multicentricity, bilaterality, and family history of mammary carcinoma Am J Clin Pathol 73 1 25 30 1:STN:280:DyaL3c7gs1Oitg%3D%3D 6243440 (Pubitemid 10180390)
17. H Jernstrom J Frenander M Ferno H Olsson 1999 Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients Br J Cancer 80 9 1453 1458 1:STN:280:DyaK1Mzlt1SgtA%3D%3D 10.1038/sj.bjc.6690543 10424750 (Pubitemid 29308617)
18. LA Brinton D Richesson MF Leitzmann, et al. 2008 Menopausal hormone therapy and breast cancer risk in the NIH-AARP Diet and Health Study Cohort Cancer Epidemiol Biomarkers Prev 17 11 3150 3160 1:CAS:528:DC%2BD1cXhtlCkur%2FF 10.1158/1055-9965.EPI-08-0435 18990757
19. L Tabar PB Dean 2003 Mammography and breast cancer: the new era Int J Gynaecol Obstet 82 3 319 326 1:STN:280:DC%2BD3svktVGqtQ%3D%3D 10.1016/S0020-7292(03)00262-5 14499978 (Pubitemid 37117450)